Scientific programme

Scientific programme

Our scientific secretary Ellen van der Schoot and chair of the Academy Diana Teo have composed an excellent scientific programme including:

Saturday, November 14

During the Indonesian half day Ubonwon (Thailand) will discuss the role of a National Blood Centre in countries with a mixed system of blood services and Chen (Taiwan) will present the consolidation of laboratories for blood testing.  The plenary session will provide examples on how to overcome resource limitations in Myanmar, Indonesia and Papua New Guinea. In a parallel scientific session on donors and donation and components Celia Tan (Singapore) will present how behavioural changes could improve donor recruitment and retention, Fitri (Indonesia), selected oral abstract, will explain how blood donation could be promoted during fasting. Thierry Burnouf (Taiwan) will present the latest developments in plasma derivative production and Gyulnar Baimukanova (USA), selected oral abstract, will discuss the effect of platelet storage temperature on the integrity of endothelial cells in the vasculature.  

Sunday, November 15

In one of the plenary sessions, Martin Olsson (Sweden) will explain why having blood group O protects against malaria and Yoshihiko Tani (Japan) will discuss the prevalence of various rare blood types in the region. The second plenary will include a presentation by Lin Fung (Australia) on a sheep model of blood transfusion. The importance of glycosylation of alloantibodies against blood cell antigens will be presented by Ellen van der Schoot (The Netherlands) in a scientific parallel session. The various issues related to blood safety will be discussed by Brian Custer (USA) and Yasmin Ayob (Malaysia) in an Academy parallel session. 

Monday, November 16

In one of the scientific sessions Kevin Baird, Professor of Malariology and Head of Unit, Eijkman Oxford Clinical Research Unit, who is located in Jakarta, will present a primer on Malaria. The emerging pathogens and their risk to transmit diseases through transfusion will be presented by Helen Faddy (Australia) and So-Yong Kwon (Korea), oral abstract, will share the Korean experiences regarding the recent outbreak of the Middle East Respiratory Syndrome Coronavirus. In one of the Academy sessions Kirwan (New Zealand) will introduce practice regarding novel blood components. In the final plenary session Viprakasit (Thailand) will provide an update on how to manage haemoglobinopathies and iron overload. Hutajulu (Indonesia) will highlight the importance of GMP supervision in blood establishments.

The programme will start with an Indonesian half day on November 14 which is being prepared by the Local Organising committee.  It will be followed by the opening ceremony and welcome lunch.  The main scientific programme will commence the afternoon of November 14, 2015.

Programme per day

Saturday November 14, 2015
08.00 – 11.45Indonesian half day

08.00 - 09.45

Opening

  • GMP vs ISO on Blood Establishment
    V. Armstrong (Australia)
  • Role of National Blood Centre in the country with mixed system of blood services
    Dr. Ubonwon (Thailand)
  • Consolidation of Laboratories for Blood Testing
    Z-W. Chen (Taiwan)
  • Panel Discussion
09.45 - 10.00Coffee Break
10.00 - 11.45
  • Blood Aphaeresis in Beijing
    Y. Qiu (China)
  • Hepatitis B update on diagnostic and screening test
    M. Tedja (Indonesia)
  • Platelet Antibody Testing
    N.K. Ritchie (Indonesia)
  • Panel Discussion
  • Closing
12.00 – 12.30Opening Ceremony
12.30 – 14.00Lunch and Welcome Reception
14.00 – 15.30Plenary 1
Overcoming Resource Limitations

  • Indonesia
    Y. Soedarmono
  • Myanmar
    T. Aung
  • Papua New Guinea
    M. Mathias
15.30 – 16.00Refreshment break
16.00 – 17.30

Parallel 1
Academy The What and How of Immunohaematology

  • Molecular applications in routine transfusion testing
    E. van der Schoot (The Netherlands)
  • How do we approach dilemmas in red cell testing
    V. Nadarajan (Malaysia)
  • How do we manage patients with rare blood types
    Z. Zhu (China)

Parallel 2
Scientific Advances in Blood Donation and Components

  • Applying behavioural change process theory to donor donor recruitment and retention
    C. Tan (Singapore)
  • Promotion of Blood Donation Programs. During Fasting Month by Participation of Group Donation in Tangerang Blood Centre
    F. Fitri (Indonesia)
  • New developments in plasma derivative production
    T. Burnouf (Taiwan)
  • Therapeutic apheresis
    T. Triyono (Indonesia)
  • The Effects of 22°C and 4°C Storage of Platelets on Vascular Endothelial Integrity in Vitro and in Vivo
    G. Baimukanova (USA)
17.30 - 18.30

Oral Selected Abstracts

  • A Murine Model Of Foetal/Neonatal Alloimmune Thrombocytopenia Caused By Cd36 Antibodies 
    X. Xu (China)
  • Deglycosylated Human Monoclonal Antibody against Hpa-1A Prevents Platelet Clearance and Endothelial Dysfunction Mediated by Anti-Hpa-1A Alloantibodies
    H.W. Wihadmadyatami (Indonesia)
  • Microrna Expression Profiles and Target Gene Analysis Identified a Novel Mirna Regulator of Ok/Bsg
    L.Y.Ye (China)
  • Antigen-Decorated Engineered Red Blood Cells as a Novel Immune Tolerance-Inducing Agent
    N.P. Pishesha (USA)
  • Critical Role of Tgf-β1 In Expanding Human Natural Regulatory T Cells And Stabilizing Ntregs under Inflammatory Conditions
    J. Sun (China)
Sunday November 15, 2015
08.30 - 10.00

Plenary 2
Issues in Immunohaematology

  • Why blood group O protects you against Malaria
    M.L. Olsson (Sweden)
  • Rare Blood types in the Asia Pacific Region
    Y. Tani (Japan)
  • The evolving role of Platelet Antigens and Antibodies
    S. Santoso (Germany)

Parallel 3
Academy The What and How of Donors and Donations

  • Planning Donor Recruitment Strategies with an Eye on the Future
    M. Satake (Japan)
  • Choosing the right Criteria for Donor Health and Safety
    N. Ishak (Malaysia)
  • Advances in Blood Storage Bags and Preservative Solutions
    W.C. Tsoi (Hong Kong)

Parallel 4
Scientific Advances in Immunohaematology

  • Red Blood Cell Genotyping in China
    Y. Li (China)
  • The Relevance of Platelet Antigen/Antibodies in Multi Ethnic Malaysia
    M.I. Armawai (Malaysia)
  • Glycosylation of Alloantibodies against Blood Cell Antigens
    E. van der Schoot (The Netherlands)
  • Adsorption of Auto- Antibodies in Patients with Aiha Helps to detect Masked Allo- Antibodies to improve Safety of Blood Transfusion
    A. Abd Elrahman (Egypt)
  • To Study the Efficacy of Cross-Match Compatible Platelets in Multi-Transfused Allo-Immunized Hematology-Oncology Patients Refractory to Platelet Transfusion
    R.R. Sharma (India)
 
12.00 - 13.30 Lunch
13.30 - 15.00

Plenary 3
Donors, Donations and Components

  • Updates in donor recruitment and management in Blood Service
    C.K. Lee (Hong Kong)
  • Baa Baa Blood Sheep
    L. Fung (Australia)
  • Developments in cell therapy in the Asia Pacific Region
    M. Koh (Singapore/United Kingdom)
15.00 - 15.30Refreshment break
15.30 - 17.00

Parallel 5
Academy The What and How of Blood Transfusion Safety

  • Assessing the risk of new emerging infections
    B. Custer (United States of America)
  • Role of a perfusionist in patient blood management
    W.T. Su (Singapore)
  • Getting the right unit to the right patient - how can we fix the problem
    Y. Ayob (Malaysia)

Parallel 6
Scientific New Perspectives in Blood Systems and Organisation

  • First steps into lean at the Australian Red Cross Blood Service
    T. Jones (Australia)
  • Haemovigilance and Patient Blood Management: a fresh Perspective  
    C. Bianco (United States of America)
  • Governance and clinical transfusion
    R. Benjamin (United States of America)
  • A Successful and Sustained  Multi-Site Platelet Wastage Minimisation Program
    R. Tocchetti (Australia)
  • Overall Discussion
 
17.00 - 18.00Poster session
19.00 - 22.00Congress party

 

 

 

Monday November 16, 2015
08.30 - 10.00

Plenary 4
All About Transfusion Transmitted Infectious Diseases

  • The problem with hepatitis
    M. Satake (Japan)
  • Pathogen reduction technology - is it time?
    S.Y. Kwon (Korea)
  • The current status of NAT in TTID
    M. Vermeulen (South Africa)

Parallel 7
Academy The What and How of Blood Components

  • Automating the production of blood components
    M. Lozano (Spain)  
  • Introducing novel blood components - principles and practice
    S. Kirwan (New Zealand)
  • GMP supervision on Blood Establishment
    T.J. Hutajulu (Indonesia)
 

Parallel 8
Scientific Advances in Blood Safety

  • A Primer on Malaria in the Asia Pacific
    K. Baird (Indonesia)
  • New strategies for bacterial decontamination
    M. Schmidt (Germany)
  • Development of a Highly Sensitive Detection Method for Bacterial DNA in Blood for Transfusion
    T.Yoshimasa (Japan)
  • Transfusion risk from emerging pathogens in the Asia Pacific Region
    H. Faddy (Australia)
  • Middle East Respiratory Syndrome Coronavirus (Mers-Cov) Outbreak in South Korea: Risk Management at the Korean Red Cross Seoul Nambu Blood Center
    E.H. Lee (South Korea)
12.00 - 13.30 Lunch
13.30 - 15.00

Parallel 9
Academy The What and How of Organisation and Blood Supply Management

  • What's the right model for the national blood programme
    P. Flanagan (New Zealand)
  • Putting in place a risk-based decision framework for blood safety
    P. McDonald (Australia)
  • Haemovigilance - setting up one from none
    N. Marwaha (India)

Parallel 10
Scientific Advances in Clinical Transfusion

 

 

  • Haemoglobinopathies in Indonesia 
    I. Setianingsih (Indonesia)
  • Optimising transfusion therapy in the chronically transfused patient
    A.L. Ang (Singapore)
  • Introduction of Point-of-Care Testing and Intervention in the Transfusion Unit Decreases Perioperative Bleeding, Shortens Operative Time and Facilitates Appropriate Dosage of Blood Transfusions
    C. Yamada (Japan)
  • Risks and Benefits of Antifibrinolytic Therapy with Tranexamic Acid Vary by Cardiovascular Surgery Type
    Y.K. Kanaumi (Japan)
  • A Comparison of Platelets Transfusion Practice in Dengue Hospitalized Patients during Separate Outbreak Years – 2005 vs 2013
    K.P. Myint (Singapore)

 

15.00 - 15.30Refreshment break
15.30 - 17.00

Plenary session 5
Clinical Transfusion Updates

  • Update on management of hemoglobinopathies and iron overload: Beyond blood transfusion
    V. Viprakasit (Thailand)
  • Update on indications for red cell transfusion
    A.L. Ang (Singapore)
  • Update on indications for platelet transfusion
    E. Wood (Australia)

 

17.00 - 17.15Closing ceremony

 

 

 

Sunday November 15, 2015

07.00 - 08.15 hours
Kayumanis Nusa Dua

Young investigators/early career scientists who are under 40 have the opportunity discuss their work and enjoy a breakfast with each other. The breakfast gives you the chance to share your successes, failures and challenges and get tips for your research with your peers and selected experts in the field of transfusion medicine.
The session will be held at Kayumanis Nusa Dua which is only a 7 minute walk from the Westin Resort. After the session, transportation to the Convention Centre is provided.

Download an application form here and submit by October 30, 2015.

 

 

Come and get tips on choosing the right material to submit and how to write your abstract/scientific paper in order to have more chance of getting it accepted. The workshop will be led by Martin Olsson.

The lunchtime workshop will be held on Monday November 16, 2015. The workshop will start at 12.30 hours in Nusantara 2.

The ISBT Working Party on Platelet Immunobiology will host a one day pre congress workshop on on Friday November 13, 2015. The programme will be educational with a mixture of presentations, discussion and case studies.

This educational workshop will take place at the Udayana University Hospital, Budang-Bali, Indonesia. The full programme can be found here.  

Topics covered will include; the current state of platelet transfusion in Indonesia, efficacy and safety of platelet transfusion, platelet antibodies and haemorrhage, platelet alloantigens and carbohydrates, platelet GPllb/llla and lb/lX antibodies in ITP, diagnostic and clinical case studies.

Participants will be accepted on a first come, first served basis and the maximum number is 40 people. If you are interested email Sentot Santoso  

Closing date is Monday November 2, 2015.

JOIN ISBT TOGETHER WE INCREASE OUR IMPACT ON TRANSFUSION MEDICINE

Quote
Quote

“Sharing the ideas with a group of like-minded friends from all over the world always lights the inspiration and pushes you forward. To join us and enjoy it!”

Ji Yanli, China
Become a member from 55,- euro p/y join us now